Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/39350| Title: | The path forward in early-stage lung cancer | Authors: | CUPPENS, Kristof Baas, Paul |
Issue Date: | 2023 | Publisher: | AME PUBLISHING COMPANY | Source: | Translational Lung Cancer Research, 12 (1) , p. 11 -13 | Notes: | Baas, P (corresponding author), Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands.; Baas, P (corresponding author), Leiden Univ, Dept Pulmonol, Med Ctr, Leiden, Netherlands. p.baas@nki.nl |
Keywords: | Early-stage lung cancer;perioperative strategy;perioperative immune checkpoint inhibition;perioperative targeted therapy | Document URI: | http://hdl.handle.net/1942/39350 | ISSN: | 2218-6751 | e-ISSN: | 2226-4477 | DOI: | 10.21037/tlcr-22-546 | ISI #: | 000907560600001 | Rights: | Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the noncommercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. | Category: | A2 | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| The path forward in early-stage lung cancer.pdf | Published version | 106.77 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.